EHA-SWG Scientific Meeting on Granulocytes and Constitutional Marrow Failure Syndromes

Dates: October 10-12, 2019
Location:
Prague, Czech Republic
Chair: C Dufour
Co-chairs: C Mecucci, H Papadaki, K de Keersmaecker

Organized by:
EHA Scientific Working Group on Granulocytes and Constitutional Marrow Failure Syndromes

Registration for this meeting is now open Register here

The second edition of this EHA-SWG Meeting on state-of-the-art of constitutional marrow failures will cover the novel aspects in chronic neutropenia. Recent developments in the pathogenesis of “classical CMFS” like ribosome and telomere disorders and Fanconi anemia will be presented. The novel area of "Leukemia Predisposition Genes" will be dealt with by providing tools on how to identify and manage patients carrying these features. Round tables will focus on the correct timing and indications of stem cell transplantation in congenital neutropenias and in CMFS and on the role of precision medicine in these diseases.

Below you can find key information and links to important details regarding registration and accommodation. There is also a wide array of sponsorship opportunities available for pharmaceutical companies.

Target audience

Hematologists, both in training (medical students) and trainees (junior doctors), doctors and scientists involved in the area of granulocyte and constitutional marrow failure syndromes.

Program

The scientific program will cover:

  • novel aspects in chronic neutropenia,
  • recent developments in the pathogenesis of “classical CMFS” like ribosome and telomere disorders and Fanconi Anemia,
  • leukemia predisposition genes, and
  • stem cell transplantation in congenital neutropenias and in CMFS and on the role of precision medicine.

Contributions tailored to the specific disease area from representatives of patients' associations, pharma and regulatory institutions will also be included. Finally, new experimental treatments for these rare diseases will be presented and discussed. The topics will be covered by worldwide renowned experts and top-ranking speakers from Europe and US. In addition two slots for selected presentations by juniors on illustrative and rare clinical cases or peculiar topics are also foreseen.

The full program can be found here.

Learning objectives

After attending this EHA-SWG Scientific Meeting, you should be able to:

  • describe the latest updates about the pathogenesis of Granulocyte and CMFD,
  • identify and appropriately manage patients, and
  • have learned about the new available treatments. 

Abstract submission

Abstract submission has closed. The submitting authors will be informed of the abstract allocation results by August 8, 2019.

For more information on the abstract submission, click here

Venue

The meeting will be held at the Hotel Occidental Praha:
Na Strži 32, 14000 Prague, Czech Republic

Key dates

Registration

Online registration is open. Benefit from the reduced early registration fee by registering before September 1, 2019; 23:59 CET.

Visit this page for more information and to register.

Sponsorship

This meeting is supported by:

Meeting partner

Takeda Oncology2


Meeting supporter

novartis logo pos rgb

 

There are various opportunities to support this meeting. For more information please send an email to sponsorship@ehaweb.org or check the sponsorship page.

EBAH CME Accreditation

EBAH accredited stamp DEF2Continuing Medical Education (CME) is widely accepted as a means to encourage individual practitioners to maintain and develop professional knowledge and skills keeping up-to-date with latest developments within the field. The meeting will be accredited by the EBAH system. Participants of this meeting are eligible to receive one Continuing Medical Education (CME) credit point for every hour of accredited activity from the EBAH system.